Sumedha Mongia MD, MBA

HIP - is an opportunistic venture capital firm that uses a unique multi-disciplinary collaborative ecosystem model to fund innovation in healthcare. A firm with a TRUE NORTH of conducting the most detailed and complete early stage diligence in the industry - HIP has grown to over 275 investors (including 90 institutional including 18 health system strategic investors). HIP endorses an opportunity for investment ONLY after its extensive diligence and deploys capital through its Fund and sidecar - deal by deal investment vehicle. In parallel - institutional investors in HIP deploy capital through their own structures and funds based on their independent decision but heavily weighed by the collective HIP endorsement and powerful HIP model/process. As of late 2024 - HIP portfolio has 12 early stage healthcare technology companies. With over 75% having received multiple rounds of funding from the HIP ecosystem. Visit our site for details to join our mission as an investor in healthcare or to seek audience for investment (fill out a short sign up form)

Citrine Angels is an angel investment organization composed of more than 80 women angel investors committed to empowering female founders and funders through investments, education and mentorship. Our focus is to provide the necessary resources, networks, and expertise to cultivate female angel investors into helping female-founded businesses grow and succeed. In an industry where capital disproportionately goes to men, Citrine Angels is the only angel investing organization in the mid-Atlantic region pledged solely to supporting female founders and funders. Since our founding in late 2019, our members - many of them first time angel investors - have invested more than $1.75M in female founded companies.

Strategic Analysis Inc. (SA) is an industry-leading government professional services firm that excels in providing innovative solutions to the problems of today and tomorrow. The talents and experience that make up the SA team provide all of the skills, tools and creative ideas necessary to address the technical, operational, programmatic, and policy aspects of national defense and homeland security issues. In addition, SA was featured in the November 2007 issue of Washingtonian Magazine-Best Places to Work. Strategic Analysis began operations in Arlington, VA in May of 1986, quickly establishing a name for itself by winning competitive contracts from the Office of Naval Research, the Office of the Secretary of Defense and the Los Alamos National Laboratory to support technical studies and key national security science and technology (S&T) programs. Years later, Strategic Analysis has grown substantially, with offices in Arlington, VA, Washington DC and Colorado Springs, CO. SAs core capabilities have also greatly expanded and diversified as new demands have been placed on the professional services industry. While SAs list of clients has grown, our core values of providing the highest quality support to our customers, hiring and building relationships with good people to do great things, a focus on SA as an "extended family,"​ and working to build a better community for everyone remain the same as they were twenty years ago.

Remmie Health is a digital health technology venture that delivers next-generation, AI-enabled, ear-nose-throat care for easier, accessible diagnosis, timely intervention, and exceptional patient care. Remmie is a patient-centric, primary care telemedicine/at-home examination device + API + AI system that enables patients/consumers to receive virtual/hybrid care from healthcare professionals, covering 22+ most commonly occurring respiratory conditions, causing over 120 million annual visits as the leading reason for ambulatory care, impacting every family 2-9 times a year. The winner of the Muse Innovation Fellowship, UCLA Knapp Venture Competition, and Rice Business Plan Competition, Remmie Health is a UnitedHealthcare Accelerator (powered by Techstars) and Plug and Play portfolio company. The company is based in Seattle, WA.

HIP - is an opportunistic venture capital firm that uses a unique multi-disciplinary collaborative ecosystem model to fund innovation in healthcare. A firm with a TRUE NORTH of conducting the most detailed and complete early stage diligence in the industry - HIP has grown to over 275 investors (including 90 institutional including 18 health system strategic investors). HIP endorses an opportunity for investment ONLY after its extensive diligence and deploys capital through its Fund and sidecar - deal by deal investment vehicle. In parallel - institutional investors in HIP deploy capital through their own structures and funds based on their independent decision but heavily weighed by the collective HIP endorsement and powerful HIP model/process. As of late 2024 - HIP portfolio has 12 early stage healthcare technology companies. With over 75% having received multiple rounds of funding from the HIP ecosystem. Visit our site for details to join our mission as an investor in healthcare or to seek audience for investment (fill out a short sign up form)

Citrine Angels is an angel investment organization composed of more than 80 women angel investors committed to empowering female founders and funders through investments, education and mentorship. Our focus is to provide the necessary resources, networks, and expertise to cultivate female angel investors into helping female-founded businesses grow and succeed. In an industry where capital disproportionately goes to men, Citrine Angels is the only angel investing organization in the mid-Atlantic region pledged solely to supporting female founders and funders. Since our founding in late 2019, our members - many of them first time angel investors - have invested more than $1.75M in female founded companies.

WellUp allows consumers to create a Covid Pass, collect their vaccine records, and share - all from their mobile phones. Schools and daycares need access to verified health data and contact-free workflows to ensure a safe environment, comply with state reporting and provide continuity of care to pediatric patients.